213 related articles for article (PubMed ID: 34026440)
1. An Insulin-Inspired Supramolecular Hydrogel for Prevention of Type 1 Diabetes.
Liu M; Wang Z; Feng D; Shang Y; Li X; Liu J; Li C; Yang Z
Adv Sci (Weinh); 2021 May; 8(10):2003599. PubMed ID: 34026440
[TBL] [Abstract][Full Text] [Related]
2. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
3. Old Dog New Tricks: PLGA Microparticles as an Adjuvant for Insulin Peptide Fragment-Induced Immune Tolerance against Type 1 Diabetes.
Liu M; Feng D; Liang X; Li M; Yang J; Wang H; Pang L; Zhou Z; Yang Z; Kong D; Li C
Mol Pharm; 2020 Sep; 17(9):3513-3525. PubMed ID: 32787283
[TBL] [Abstract][Full Text] [Related]
4. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Insulin Peptide Autoantigen Delivery by Mannosylated Sodium Alginate Nanoparticles Delayed but Could Not Prevent the Onset of Type 1 Diabetes in Nonobese Diabetic Mice.
Qu Y; Shi H; Liu M; Zhang M; Wang H; Pang L; Zhang C; Kong D; Li C
Mol Pharm; 2021 Apr; 18(4):1806-1818. PubMed ID: 33734705
[TBL] [Abstract][Full Text] [Related]
6. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
8. Parameters influencing antigen-specific immunotherapy for type 1 diabetes.
Wang B; Tisch R
Immunol Res; 2008; 41(3):175-87. PubMed ID: 18543112
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
Prasad S; Kohm AP; McMahon JS; Luo X; Miller SD
J Autoimmun; 2012 Dec; 39(4):347-53. PubMed ID: 22647732
[TBL] [Abstract][Full Text] [Related]
10. Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8
Reeves PLS; Rudraraju R; Wong FS; Hamilton-Williams EE; Steptoe RJ
Eur J Immunol; 2017 Sep; 47(9):1550-1561. PubMed ID: 28665492
[TBL] [Abstract][Full Text] [Related]
11. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
12. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin.
Zhang W; Jin H; Hu Y; Yu Y; Li X; Ding Z; Kang Y; Wang B
Hum Gene Ther; 2010 Feb; 21(2):171-8. PubMed ID: 19788384
[TBL] [Abstract][Full Text] [Related]
13. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
14. Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the NOD Mouse.
Jamison BL; DiLisio JE; Beard KS; Neef T; Bradley B; Goodman J; Gill RG; Miller SD; Baker RL; Haskins K
Diabetes; 2022 Mar; 71(3):483-496. PubMed ID: 35007324
[TBL] [Abstract][Full Text] [Related]
15. Arrest in the Progression of Type 1 Diabetes at the Mid-Stage of Insulitic Autoimmunity Using an Autoantigen-Decorated All-
Phillips BE; Garciafigueroa Y; Engman C; Liu W; Wang Y; Lakomy RJ; Meng WS; Trucco M; Giannoukakis N
Front Immunol; 2021; 12():586220. PubMed ID: 33763059
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment.
Zhang J; Gao W; Yang X; Kang J; Zhang Y; Guo Q; Hu Y; Xia G; Kang Y
PLoS One; 2013; 8(7):e70056. PubMed ID: 23894591
[TBL] [Abstract][Full Text] [Related]
17. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
[TBL] [Abstract][Full Text] [Related]
18. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
[TBL] [Abstract][Full Text] [Related]
19. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
